Patents by Inventor Sara Marinelli

Sara Marinelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic use of the botulinum neurotoxin serotype A
    Patent number: 10780149
    Abstract: A new therapeutic use of botulinum neurotoxin serotype A (Bont/A) is described, in the therapeutic treatment of paralysis caused by spinal cord injury.
    Type: Grant
    Filed: January 21, 2019
    Date of Patent: September 22, 2020
    Assignee: CONSIGLIO NAZIONALE DELLE RICERCHE
    Inventors: Sara Marinelli, Flaminia Pavone, Siro Luvisetto, Valentina Vacca
  • THERAPEUTIC USE OF THE BOTULINUM NEUROTOXIN SEROTYPE A
    Publication number: 20190224288
    Abstract: A new therapeutic use of botulinum neurotoxin serotype A (Bont/A) is described, in the therapeutic treatment of paralysis caused by spinal cord injury.
    Type: Application
    Filed: January 21, 2019
    Publication date: July 25, 2019
    Applicant: Consiglio Nazionale Delle Ricerche
    Inventors: Sara Marinelli, Flaminia Pavone, Siro Luvisetto, Valentina Vacca
  • A NEW THERAPEUTIC USE OF THE BOTULINUM NEUROTOXIN SEROTYPE A
    Publication number: 20180140685
    Abstract: A new therapeutic use of botulinum neurotoxin serotype A (Bont/A) is described, therapeutic treatment of paralysis caused by spinal cord injury.
    Type: Application
    Filed: April 21, 2016
    Publication date: May 24, 2018
    Applicant: Consiglio Nazionale Delle Ricerche
    Inventors: Sara Marinelli, Flaminia Pavone, Siro Luvisetto, Valentina Vacca
  • Method for the potentiation of opioid analgesics effects on pain
    Patent number: 8715666
    Abstract: According to the invention there is provided use of an anti-TrkA antibody capable of inhibiting the binding between NGF and TrkA combined with at least one opioid analgesic for the preparation of a medicament for treating and/or preventing pain.
    Type: Grant
    Filed: June 23, 2011
    Date of Patent: May 6, 2014
    Assignee: Lay Line Genomics S.p.A.
    Inventors: Flaminia Pavone, Sara Marinelli, Antonio Cattaneo, Gabriele Ugolini
  • Analgesic treatment with prolonged effect
    Patent number: 8691221
    Abstract: Use of an anti-TrkA antibody capable of inhibiting the binding between NGF and TrkA, in particular capable of blocking the biological activity of TrkA, for the preparation of a medicament for treating and/or preventing chronic pain.
    Type: Grant
    Filed: June 7, 2006
    Date of Patent: April 8, 2014
    Assignee: Lay Line Genomics S.p.A.
    Inventors: Flaminia Pavone, Sara Marinelli, Antonio Cattaneo, Gabriele Ugolini
  • METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN
    Publication number: 20120213784
    Abstract: According to the invention there is provided use of an anti-TrkA antibody capable of inhibiting the binding between NGF and TrkA combined with at least one opioid analgesic for the preparation of a medicament for treating and/or preventing pain.
    Type: Application
    Filed: June 23, 2011
    Publication date: August 23, 2012
    Applicant: LAY LINE GENOMICS S.p.A.
    Inventors: FLAMINIA PAVONE, SARA MARINELLI, ANTONIO CATTANEO, GABRIELE UGOLINI
  • Method for the potentiation of opioid analgesics effects on pain
    Patent number: 7988966
    Abstract: According to the invention there is provided use of an anti-TrkA antibody capable of inhibiting the binding between NGF and TrkA combined with at least one opioid analgesic for the preparation of a medicament for treating and/or preventing pain.
    Type: Grant
    Filed: June 23, 2006
    Date of Patent: August 2, 2011
    Assignee: Lay Line Genomics S.p.A.
    Inventors: Flaminia Pavone, Sara Marinelli, Antonino Cattaneo, Gabriele Ugolini
  • Novel Analgesic Treatment with Prolonged Effect
    Publication number: 20100291083
    Abstract: Use of an anti-TrkA antibody capable of inhibiting the binding between NGF and TrkA, in particular capable of blocking the biological activity of TrkA, for the preparation of a medicament for treating and/or preventing chronic pain.
    Type: Application
    Filed: June 7, 2006
    Publication date: November 18, 2010
    Applicant: NOVARTIS VACCINES AND DIAGONOSTICS
    Inventors: Flaminia Pavone, Sara Marinelli, Antonio Cattaneo, Gabriele Ugolini
  • Method for the potentiation of opioid analgesics effects on pain
    Publication number: 20090123464
    Abstract: According to the invention there is provided use of an anti-TrkA antibody capable of inhibiting the binding between NGF and TrkA combined with at least one opioid analgesic for the preparation of a medicament for treating and/or preventing pain.
    Type: Application
    Filed: June 23, 2006
    Publication date: May 14, 2009
    Applicant: Lay Line Genomics S.p.A.
    Inventors: Flaminia Pavone, Sara Marinelli, Antonino Cattaneo, Gabriele Ugolini